Select another
Cluster
Join us on Twitter Join us on Linkedin Become a member Subscribe to the newsletter

Luxembourg BioHealth Cluster

The Luxembourg BioHealth Cluster is a young emerging Cluster aiming to reinforce and capitalise on the National Strategy developed by the Government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine, and to enhance the Grand Duchy's reputation as a recognised and attractive environment for biomedical research, development, innovation (RDI) and business.

Our members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, providers of capital and services…) based in Luxembourg whose activities are related to Health Sciences and Technologies. With a principal focus on molecular diagnostics, the Cluster’s umbrella also covers other RDI/business domains that are key elements in an integrated patient-based personalised medicine approach, such as new therapeutics, bioinformatics, medical device and telemedicine. Supporting this dynamic and steadily growing biocommunity is our main objective. Therefore, we provide our members with a portfolio of added-value activities and services to support them in their daily RDI and/or business challenges and to increase their national and international visibility and attractiveness. 

News

  • 20-10-2014 BioHealth Cluster visits Luxair Cargo’s Pharma and Healthcare Centre

    The latest Cluster Networking Event gave our members the opportunity to visit the Pharma&Healthcare Centre and learn more about recent and future developments of the Pharmalogistics hub at the Luxembourg airport.

  • 09-10-2014 A journey into the microcosm

    Dr Paul Wilmes’ Eco-Systems Biology group at the Luxembourg Centre for Systems Biomedicine investigates the complex interactions within microbial ecosystems to help improve the environment and bring advances in human healthcare. An article in the latest issue of FOCUS on Research and Innovation in Luxembourg presents his key research priorities.

  • 01-10-2014 Progress for early detection of colon cancer

    Three years of successful collaboration between Luxembourg’s researchers, clinicians and IBBL (Integrated BioBank of Luxembourg) have led to the discovery of 2 molecules potentially suitable for early diagnosis of colorectal cancer.